These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1645436)

  • 1. Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum.
    Augood SJ; Kiyama H; Faull RL; Emson PC
    Brain Res Mol Brain Res; 1991 Mar; 9(4):341-6. PubMed ID: 1645436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum.
    Augood SJ; Kiyama H; Faull RL; Emson PC
    Neuroscience; 1991; 44(1):35-44. PubMed ID: 1685231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ; Hunt SP
    Neurosci Lett; 1991 Apr; 125(2):201-4. PubMed ID: 1831887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ
    J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.
    Glavan G; Sket D; Zivin M
    Mol Pharmacol; 2002 Feb; 61(2):360-8. PubMed ID: 11809861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge.
    Daunais JB; McGinty JF
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):237-48. PubMed ID: 8717360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain.
    Kopp J; Lindefors N; Brené S; Hall H; Persson H; Sedvall G
    Neuroscience; 1992; 47(4):771-9. PubMed ID: 1533704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
    Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
    Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats.
    Kiyatkin EA; Rebec GV
    J Neurosci; 1999 May; 19(9):3594-609. PubMed ID: 10212318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.